Legislation

Title: Investigational Drugs, Biological Products, and Devices - Right to Try Act
Sponsored by: Senator Simonaire
Status: In the Senate - Withdrawn by Sponsor
Analysis: Fiscal and Policy Note

Synopsis

Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; specifying the manner in which a specified drug, product, or device may be provided to eligible patients; prohibiting a health occupations board from taking specified action against a health care provider's license on a specified basis; establishing that the Act does not create a specified cause of action; etc.

Committees

Original:: Finance Click to view Recorded Media

Details

Cross-filed with: HB0056

Bill File Type: Pre-Filed

Effective Date(s): October 1, 2016

History

Legislation History
Chamber Senate Calendar Date 12/16/2015 Legislative Date 7/22/2015 Action Pre-filed Proceedings
Chamber Senate Calendar Date 12/16/2015 Legislative Date 1/13/2016 Action First Reading Finance Proceedings
Chamber Senate Calendar Date 1/13/2016 Legislative Date 1/13/2016 Action Hearing 1/28 at 1:00 p.m. Proceedings
Chamber Senate Calendar Date 3/15/2016 Legislative Date 3/16/2016 Action Unfavorable Report by Finance; Withdrawn Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	12/16/2015	7/22/2015	Pre-filed
Senate	12/16/2015	1/13/2016	First Reading Finance
Senate	1/13/2016	1/13/2016	Hearing 1/28 at 1:00 p.m.
Senate	3/15/2016	3/16/2016	Unfavorable Report by Finance; Withdrawn

Documents

Date Posted	Document Name
12/17/2015	Text - First - Investigational Drugs, Biological Products, and Devices - Right to Try Act
3/16/2016	Vote - Senate - Committee - Finance

File Code

Subjects

Statutes